Fesarius Therapeutics demonstrates the science that establishes DermiSphere™ hDRT in a class of its own

B NEW YORK, April 30, 2026 /PRNewswire/ — FesariusTherapeutics, Inc., a commercial stage bioregenerative technology company focused on the development, manufacture and commercialization of solutions…
posteditor
posteditor
Articles: 17424

Other News